BIX02188 (c)

CAS No. 1094614-84-2

BIX02188 (c)( —— )

Catalog No. M10367 CAS No. 1094614-84-2

BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 139 In Stock
2MG 57 In Stock
5MG 122 In Stock
10MG 229 In Stock
25MG 345 In Stock
50MG 507 In Stock
100MG 730 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BIX02188 (c)
  • Note
    Research use only, not for human use.
  • Brief Description
    BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM.
  • Description
    BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    ERK5| MEK1| MEK2| MEK5| TGFβR1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1094614-84-2
  • Formula Weight
    412.48
  • Molecular Formula
    C25H24N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 100 mM
  • SMILES
    CN(C)CC1=CC(=CC=C1)N/C(=C\2/C3=C(C=C(C=C3)C(=O)N)NC2=O)/C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tatake RJ, et al. Biochem Biophys Res Commun, 2008, 377(1), 120-125.
molnova catalog
related products
  • ERK-IN-3

    ERK-IN-3 is a potent and orally active inhibitor of ERK. It inhibits ERK1/2 with low single-digit nM IC50 values. It can be used for the research of cancers driven by RAS mutations.

  • ASTX029

    ASTX029 is a selective and orally bioavailable extracellular signal-regulated kinases 1 and 2 (ERK 1/2) inhibitor, with potential antineoplastic activity.

  • GSK2656157

    GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay.